Literature DB >> 1673875

Antibody responses in HIV infection.

A J Pinching1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1673875      PMCID： PMC1535392     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  28 in total

Review 1.  Markers for progression in HIV infection.

Authors:  J M Lange; F de Wolf; J Goudsmit
Journal:  AIDS       Date:  1989       Impact factor: 4.177

2.  IgD production and other lymphocyte functions in HIV infection: immaturity and activation of B cells at different clinical stages.

Authors:  L A Rogers; S M Forster; A J Pinching
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

3.  Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients.

Authors:  M Opravil; W Fierz; L Matter; J Blaser; R Lüthy
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

4.  Impaired anti-pneumococcal antibody response in patients with AIDS-related persistent generalized lymphadenopathy.

Authors:  J J Ballet; G Sulcebe; L J Couderc; F Danon; C Rabian; M Lathrop; J P Clauvel; M Seligmann
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

5.  Class-specific antibody response to pneumococcal capsular polysaccharides in men infected with human immunodeficiency virus type 1.

Authors:  E N Janoff; J M Douglas; M Gabriel; M J Blaser; A J Davidson; D L Cohn; F N Judson
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

6.  Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men.

Authors:  K L Huang; F L Ruben; C R Rinaldo; L Kingsley; D W Lyter; M Ho
Journal:  JAMA       Date:  1987-04-17       Impact factor: 56.272

7.  Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome.

Authors:  H C Lane; H Masur; L C Edgar; G Whalen; A H Rook; A S Fauci
Journal:  N Engl J Med       Date:  1983-08-25       Impact factor: 91.245

8.  Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity.

Authors:  O Martínez-Maza; E Crabb; R T Mitsuyasu; J L Fahey; J V Giorgi
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

9.  An immunohistological approach to persistent lymphadenopathy and its relevance to AIDS.

Authors:  G Janossy; A J Pinching; M Bofill; J Weber; J E McLaughlin; M Ornstein; K Ivory; J R Harris; M Favrot; D C Macdonald-Burns
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

10.  Defective humoral immunity in pediatric acquired immune deficiency syndrome.

Authors:  L J Bernstein; H D Ochs; R J Wedgwood; A Rubinstein
Journal:  J Pediatr       Date:  1985-09       Impact factor: 4.406
View more
  7 in total

Review 1.  B cell responses to HIV and the development of human monoclonal antibodies.

Authors:  J E Boyd; K James
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

2.  Anti-phospholipid antibodies and CD5+ B cells in HIV infection.

Authors:  T Grünewald; G R Burmester; W Schüler-Maué; F Hiepe; F Buttgereit
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

Review 3.  Antigen-dependent and -independent mechanisms of T and B cell hyperactivation during chronic HIV-1 infection.

Authors:  Anna Haas; Kathrin Zimmermann; Annette Oxenius
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

Review 4.  Does intravenous immune globulin have a role in HIV-infected patients?

Authors:  P L Yap
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

5.  Association of phenotypic changes in B cell lymphocytes and plasma viral load in human immunodeficiency virus-infected patients.

Authors:  M R Dawood; B Conway; P Patenaude; F Janmohamed; J S Montaner; M V O'Shaughnessy; G W Hammond
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

Review 6.  Should patients positive for HIV infection receive pneumococcal vaccine?

Authors:  A Jain; S Jain; V Gant
Journal:  BMJ       Date:  1995-04-22

7.  Defective IgG2 response to Pneumovax in HIV seropositive patients.

Authors:  D J Unsworth; D Rowen; C Carne; C Sonnex; T Baglin; D L Brown
Journal:  Genitourin Med       Date:  1993-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.